ArticleBMC pulmonary medicine2021

Circulating activated immune cells as a potential blood biomarkers of non-small cell lung cancer occurrence and progression.

Yingyi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.